Insiders · Profile

Litchev Boyan Vesselinov

Chief Medical Officer at Indaptus Therapeutics. Filing since 31 Jan 2022. CIK 0001902726

Company
Date
Role
Action
Shares
Amount
Of holding
1 Dec 2022
Chief Medical Officer
Bought
500
$935.45
76.9%
22 Nov 2022
Chief Medical Officer
Bought
500
$915.00
333%
2 Mar 2022
Chief Medical Officer
Bought
50
$204.63
50.0%
31 Jan 2022
Chief Medical Officer
Bought
100
$465.00
opened
4 decisions on file.